KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Rigel Pharmaceuticals (RIGL) Leases (2019 - 2025)

Rigel Pharmaceuticals has reported Leases over the past 7 years, most recently at $920000.0 for Q4 2025.

  • Quarterly results put Leases at $920000.0 for Q4 2025, up 273.98% from a year ago — trailing twelve months through Dec 2025 was $920000.0 (up 273.98% YoY), and the annual figure for FY2025 was $920000.0, up 273.98%.
  • Leases for Q4 2025 was $920000.0 at Rigel Pharmaceuticals, down from $1.0 million in the prior quarter.
  • Over the last five years, Leases for RIGL hit a ceiling of $15.9 million in Q1 2021 and a floor of $246000.0 in Q4 2024.
  • Median Leases over the past 5 years was $1.2 million (2023), compared with a mean of $4.0 million.
  • Biggest five-year swings in Leases: plummeted 85.03% in 2023 and later soared 273.98% in 2025.
  • Rigel Pharmaceuticals' Leases stood at $9.7 million in 2021, then tumbled by 80.11% to $1.9 million in 2022, then plummeted by 55.39% to $861000.0 in 2023, then tumbled by 71.43% to $246000.0 in 2024, then soared by 273.98% to $920000.0 in 2025.
  • The last three reported values for Leases were $920000.0 (Q4 2025), $1.0 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.